InvestorsHub Logo

scalpel

01/06/15 5:49 PM

#19547 RE: DukeSilver #19546

Spot on Duke. Couldn't have said it any more eloquently than that!

Bristol19

01/06/15 6:42 PM

#19549 RE: DukeSilver #19546

Duke, I agree with you completely, nice opinion.

Not that it does away with some nagging questions I have as one of the medical guy camp.

Nothing on the horizon that anyone has detected even close to where Titan is at, even with the delay for more indications. Discount TRXC because I also believe it is a dead end. So, as always, only ISRG is a player at this time, for general surgery (not ortho and highly specialized systems like Maazor).

Now consider: Lots of articles trumpeting surgical robotics as a huge market. Only one player and Titan alone in the wings.

WHY AREN'T INVESTORS LOOKING FOR THE NEXT BIG MEDICAL ENTRY INTO SURGICAL ROBOTICS INVESTING?
WHO CAN BELIEVE $1.20 pps, even with a 1.5 year timeline?

I just can't believe the lack of interest in this company. Is it only the exchange they are on that puts them so far out in left field that intelligent money can't see the potential. Remember, even before the delay announcement, we weren't exactly seeing a run up in pps. (I consider the improvement from the $0.40 low to $2.50 as common sense, and nothing to be exited about, unless one bought in at the low)

elcaribes

01/07/15 7:55 AM

#19565 RE: DukeSilver #19546

Duke - I sincerely appreciate your opinion but at this point in time to state that Titan may one day compete with ISRG is so far out in left field that it's ridiculous. I too use to think that and I would still think that if management believed in transparency and if our share price was somewhere between $4 and $10 but with ISRG's market cap now at $19B and Titan's market cap at $118M that pretty much puts things in perspective on how the market perceives Titan's chances of ever competing with ISRG.